Illinois Administrative Code
Title 32 - ENERGY
Part 335 - MEDICAL USE OF RADIOACTIVE MATERIAL
Subpart B - GENERAL ADMINISTRATIVE REQUIREMENTS
Section 335.1110 - Written Directives
Current through Register Vol. 48, No. 12, March 22, 2024
a) A written directive shall be dated and signed by an authorized user before the administration of I-131 sodium iodide greater than 1.11 MBq (30 µCi), any therapeutic dosage of unsealed radioactive material or any therapeutic dose of radiation from radioactive material. If, because of the emergent nature of the patient's condition, a delay in order to provide a written directive would jeopardize the patient's health, an oral directive is acceptable. The information contained in the oral directive shall be documented as soon as possible in writing in the patient's record. A written directive shall be prepared within 48 hours after the oral directive.
b) The written directive shall contain the patient's or human research subject's name and the following information:
c) A written revision to an existing written directive may be made if the revision is dated and signed by an authorized user before the administration of the dosage of unsealed radioactive material, the brachytherapy dose, the gamma stereotactic radiosurgery dose, the teletherapy dose or the next fractional dose. If, because of the patient's condition, a delay in order to provide a written revision to an existing written directive would jeopardize the patient's health, an oral revision to an existing written directive is acceptable. The oral revision shall be documented as soon as possible in the patient's record. A revised written directive shall be signed by the authorized user within 48 hours after the oral revision.
d) A licensee shall retain a copy of each written directive as required by subsections (a) and (c) for 5 years.